Cancer incidence in TNF inhibitor treated patients with axial spondyloarthritis and psoriatic arthritis: a study from the ARTIS and Danbio registers

J. Askling, Lene Dreyer, Merete Lund Hetland, L. Jacobsson, L.-E. Kristensen, Bente Glintborg, Karin Hellgren, ARTIS and DANBIO study groups

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftArthritis & Rheumatology
Vol/bind66
Udgave nummerS10
Sider (fra-til)S377-8
Antal sider2
ISSN2326-5205
DOI
StatusUdgivet - 2014
Udgivet eksterntJa
Begivenhed2014 ACR/ARHP Annual Meeting - Boston, USA
Varighed: 14 nov. 201419 nov. 2014

Konference

Konference2014 ACR/ARHP Annual Meeting
LandUSA
ByBoston
Periode14/11/201419/11/2014

Bibliografisk note

Abstract no. 853

Citationsformater

Askling, J., Dreyer, L., Hetland, M. L., Jacobsson, L., Kristensen, L-E., Glintborg, B., Hellgren, K., & ARTIS and DANBIO study groups (2014). Cancer incidence in TNF inhibitor treated patients with axial spondyloarthritis and psoriatic arthritis: a study from the ARTIS and Danbio registers. Arthritis & Rheumatology, 66(S10), S377-8. https://doi.org/10.1002/art.38914